Misinformation Prompted Six Court Cases Against EU COVID-19 Vaccine Approvals In 2021
Executive Summary
The EU’s conditional approval of four COVID-19 vaccines and its decision to extend the use of Pfizer/BioNTech’s Comirnaty to a younger age group were challenged in the court last year but the cases were declared inadmissible.
You may also be interested in...
COVID-19 Has ‘Permanently Changed’ How The EMA Works
During the pandemic, the EU drugs regulator became more flexible and agile and went beyond the formal boundaries of its mandate, says its executive director Emer Cooke, who also warns of the need for the agency to retain the trust of the public.
Coronavirus Notebook: Janssen Vaccine Approved In GB, Comirnaty Cleared in EU for 12-15 Year Olds
With the spread of virus variants causing growing concern, the World Health Organization has come up with a user-friendly variant naming scheme that will simplify reporting and help avoid the stigma attached to naming new strains after the place they were first detected.
FDA Autism Meeting: Will It Stray From Symptoms And Treatments To Causation?
US agency may face challenge of keeping May 4 meeting on patient-focused drug development focused on autism disease burden and current therapeutic approaches rather than vaccine safety.